Literature DB >> 6118410

Noradrenergic component in the vasoconstriction induced by 5-hydroxytryptamine in goat cerebral arteries.

J Marin, M Salaices, B Gómez, S Lluch.   

Abstract

5-Hydroxytryptamine (5-HT) elicited dose-dependent increases in tension in the middle cerebral artery of the goat, which were significantly antagonized by lysergic acid diethylamide (LSD, 10(-8) M) and methysergide (10(-7) M). In the presence of phentolamine (10(-6) M), the dose-response curve to 5-HT was shifted to the right, the pA2 value for this antagonism was 6.52. Pretreatment of goats with reserpine (0.02 mg kg-1 day-1 for three days) or removal of both superior cervical ganglia 15 days before the experiment brought about a significant decrease in the vasoconstriction induced by doses of 5-HT higher than 10(-7) M. The remaining contraction produced by 5-HT in arterial segments from reserpinized or gangliectomized goats was further reduced in the presence of LSD. In addition, high concentrations of 5-HT induced tritium release from goat pial arteries preloaded with (-)-[3H]noradrenaline, 2 X 10(-7) M) which was significantly decreased in vessels from gangliectomized or reserpinized goats. These results in goat cerebral arteries indicate that in the contraction evoked by 5-HT there are two components. The first appears with low concentrations (up to 10(-7) M) in which 5-HT acts directly on 5-HT receptors. The second occurs at high doses (greater than 10(-7) M) in which 5-HT also acts indirectly on alpha-adrenoceptors by release of noradrenaline from noradrenergic nerve endings.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6118410     DOI: 10.1111/j.2042-7158.1981.tb13911.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  8 in total

1.  Characterization of the 5-hydroxytryptamine receptors mediating contraction in the pig isolated intravesical ureter.

Authors:  Medardo Hernández; María Victoria Barahona; Ulf Simonsen; Paz Recio; Luis Rivera; Ana Cristina Martínez; Albino García-Sacristán; Luis M Orensanz; Dolores Prieto
Journal:  Br J Pharmacol       Date:  2003-01       Impact factor: 8.739

2.  An operational model of pharmacological agonism: the effect of E/[A] curve shape on agonist dissociation constant estimation. 1985.

Authors:  J W Black; P Leff; N P Shankley; J Wood
Journal:  Br J Pharmacol       Date:  2010-07       Impact factor: 8.739

3.  An operational model of pharmacological agonism: the effect of E/[A] curve shape on agonist dissociation constant estimation.

Authors:  J W Black; P Leff; N P Shankley; J Wood
Journal:  Br J Pharmacol       Date:  1985-02       Impact factor: 8.739

4.  The classification of peripheral 5-HT2-like receptors using tryptamine agonist and antagonist analogues.

Authors:  P Leff; G R Martin; J M Morse
Journal:  Br J Pharmacol       Date:  1986-11       Impact factor: 8.739

5.  Differential classification of vascular smooth muscle and endothelial cell 5-HT receptors by use of tryptamine analogues.

Authors:  P Leff; G R Martin; J M Morse
Journal:  Br J Pharmacol       Date:  1987-06       Impact factor: 8.739

6.  Differences in agonist dissociation constant estimates for 5-HT at 5-HT2-receptors: a problem of acute desensitization?

Authors:  P Leff; G R Martin
Journal:  Br J Pharmacol       Date:  1988-10       Impact factor: 8.739

7.  Effects of 5-hydroxytryptamine on human isolated placental chorionic arteries and veins.

Authors:  J Reviriego; J Marín
Journal:  Br J Pharmacol       Date:  1989-04       Impact factor: 8.739

8.  Peripheral 5-HT2-like receptors. Can they be classified with the available antagonists?

Authors:  P Leff; G R Martin
Journal:  Br J Pharmacol       Date:  1986-07       Impact factor: 8.739

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.